For research use only.
Adipotide
Adipotide is a lab-made peptide designed to home to blood vessels in white fat and trigger their breakdown, studied in animals as a way to reduce fat tissue.[1][2]
Origin: Built from a fat-vasculature-homing sequence (CKGGRAKDC) found by phage display, linked to a death-inducing motif; early work came from Kolonin, Arap, Pasqualini and colleagues.[1]
Research areas
Published animal studies point to several research angles.
Evidence level
Level 1 of 4: Lab and animal onlyPublished adipotide work is in mice and obese monkeys, not controlled trials in people.[1][2]
Why so few human trials?Cautions
Studies and regulators point to several reasons for care.
- Findings come from animal models; human safety and effectiveness are not established in published trials[1][2]
- Targeting blood vessels in fat raises theoretical concerns about off-target vessel effects that have not been settled in people[1][2]
Adipotide is not FDA approved.
Adipotide goes by several names.
Storage basics General
These general basics apply to most freeze-dried research peptides.
Sources and studies
These studies and official pages are the research behind this profile.
- 1Reversal of obesity by targeted ablation of adipose tissueKolonin MG, et al. (2004) · Nature Medicine
- 2A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeysBarnhart KF, et al. (2011) · Science Translational Medicine
- 3Rapid and weight-independent improvement of glucose tolerance induced by a peptide designed to elicit apoptosis in adipose tissue endotheliumHossen MN, et al. (2012) · PloS One